# Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

> **NCT03441893** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan** · enrollment: 300 (estimated)

## Conditions studied

- Ulcerative Colitis
- Ulcerative Colitis Exacerbation
- Protozoan Infections
- Helminth Infection

## Interventions

- **DIAGNOSTIC_TEST:** parasitological diagnostics (coproscopy)
- **DRUG:** Nitazoxanide 500Mg Oral Tablet
- **DRUG:** Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
- **DRUG:** Mesalazine 250Mg
- **DRUG:** Placebo tabletes

## Key facts

- **NCT ID:** NCT03441893
- **Lead sponsor:** Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03441893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03441893, "Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03441893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*